bioMérieux: raises targets for FY 2020
(CercleFinance.com) - bioMérieux states that it now expects FY 2020 LFL sales growth of around 18%, and contributory underlying operating income of around 600 million euros.
For the record, last October the specialist in in vitro diagnostics said that it expected less - LFL sales growth of over 16%, with contributory underlying operating income of over 520 million euros.
Copyright (c) 2020 CercleFinance.com. All rights reserved.